| 000 | 02388 a2200601 4500 | ||
|---|---|---|---|
| 005 | 20250515140648.0 | ||
| 264 | 0 | _c20090130 | |
| 008 | 200901s 0 0 eng d | ||
| 022 | _a0363-6135 | ||
| 024 | 7 |
_a10.1152/ajpheart.00541.2008 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLeBlanc, Amanda J | |
| 245 | 0 | 0 |
_aAge impairs Flk-1 signaling and NO-mediated vasodilation in coronary arterioles. _h[electronic resource] |
| 260 |
_bAmerican journal of physiology. Heart and circulatory physiology _cDec 2008 |
||
| 300 |
_aH2280-8 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAcetylcholine _xpharmacology |
| 650 | 0 | 4 | _aAge Factors |
| 650 | 0 | 4 |
_aAging _xmetabolism |
| 650 | 0 | 4 |
_aAndrostadienes _xpharmacology |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aArterioles _xenzymology |
| 650 | 0 | 4 | _aBlood Flow Velocity |
| 650 | 0 | 4 |
_aCinnamates _xpharmacology |
| 650 | 0 | 4 |
_aCoronary Circulation _xdrug effects |
| 650 | 0 | 4 |
_aCoronary Vessels _xdrug effects |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aHydrazines _xpharmacology |
| 650 | 0 | 4 | _aIn Vitro Techniques |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aNG-Nitroarginine Methyl Ester _xpharmacology |
| 650 | 0 | 4 |
_aNitric Oxide _xmetabolism |
| 650 | 0 | 4 |
_aNitric Oxide Donors _xpharmacology |
| 650 | 0 | 4 |
_aNitric Oxide Synthase Type III _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aPhosphatidylinositol 3-Kinases _xmetabolism |
| 650 | 0 | 4 | _aPhosphoinositide-3 Kinase Inhibitors |
| 650 | 0 | 4 | _aPhosphorylation |
| 650 | 0 | 4 |
_aProto-Oncogene Proteins c-akt _xmetabolism |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
| 650 | 0 | 4 | _aStress, Mechanical |
| 650 | 0 | 4 |
_aVascular Endothelial Growth Factor A _xmetabolism |
| 650 | 0 | 4 |
_aVascular Endothelial Growth Factor Receptor-2 _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aVasodilation _xdrug effects |
| 650 | 0 | 4 |
_aVasodilator Agents _xpharmacology |
| 650 | 0 | 4 | _aWortmannin |
| 700 | 1 | _aShipley, Robert D | |
| 700 | 1 | _aKang, Lori S | |
| 700 | 1 | _aMuller-Delp, Judy M | |
| 773 | 0 |
_tAmerican journal of physiology. Heart and circulatory physiology _gvol. 295 _gno. 6 _gp. H2280-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1152/ajpheart.00541.2008 _zAvailable from publisher's website |
| 999 |
_c18301983 _d18301983 |
||